Cardioxane (Clinigen Healthcare Ltd)
Welcome to the PulseAid listing for the Cardioxane drug offered from Clinigen Healthcare Ltd. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Clinigen Healthcare Ltd |
NON-PROPRIETARY NAME: | dexrazoxane |
SUBSTANCE NAME: | DEXRAZOXANE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-07-28 |
END MARKETING DATE: | 0000-00-00 |
Cardioxane HUMAN PRESCRIPTION DRUG Details:
Item Description | Cardioxane from Clinigen Healthcare Ltd |
LABELER NAME: | Clinigen Healthcare Ltd |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2017-07-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76310-002_5a881549-9d86-4ff7-b4ab-2cfb315f9af3 |
PRODUCT NDC: | 76310-002 |
APPLICATION NUMBER: | |
Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: